[{"target":27,"price":9.190,"returns":194,"ticker":"OPTN","note":"Optinose Inc (OPTN): Cantor Fitzgerald Maintains Buy Rating Today, Has a Target of $27/Share - MoneyMakingArticles","to_char":"03/21/2019","q_eps":null,"a_eps":-2.680,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":12,"price":4.360,"returns":175,"ticker":"APTX","note":"Cantor Fitzgerald Lowers Aptinyx (APTX) Price Target to $12.00 - Fairfield Current","to_char":"03/24/2019","q_eps":null,"a_eps":-2.630,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":4,"price":1.580,"returns":153,"ticker":"SMTS","note":"HC Wainwright Analysts Give Sierra Metals (SMTS) a $4.00 Price Target - Fairfield Current","to_char":"03/24/2019","q_eps":null,"a_eps":0.140,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":10,"price":4.700,"returns":113,"ticker":"DFFN","note":"HC Wainwright Increases Diffusion Pharmaceuticals (DFFN) Price Target to $10.00 - Fairfield Current","to_char":"03/21/2019","q_eps":null,"a_eps":-5.440,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null},{"target":205,"price":122.260,"returns":68,"ticker":"SRPT","note":"Analysts Are Justifying Sarepta Therapeutics, Inc. (NASDAQ:SRPT)'s $205.13 Target - Martin Business Telegraph","to_char":"03/23/2019","q_eps":null,"a_eps":-5.460,"report":"analyst","q_pe":null,"a_pe":null,"divyield":null}]
